AI Article Synopsis

  • * An 8-year-old boy with this disorder had a specific genetic mutation in the CD79A gene and developed difficult-to-treat leg ulcers caused by Helicobacter bilis, despite regular treatments like intravenous immunoglobulin and antibiotics.
  • * The case highlights the necessity of accurate genetic diagnosis and specialized antimicrobial treatments when dealing with infections in patients with primary immunodeficiencies, especially those linked to CD79A mutations.

Article Abstract

Autosomal recessive agammaglobulinemia is a severe primary antibody deficiency disorder typically presenting in infancy. We present a rare case of an 8-year-old boy with AR agammaglobulinemia due to a homozygous splice site variant (c.499-1G > A) in the CD79A gene. Despite monthly intravenous immunoglobulin replacement and prophylactic antibiotics, he developed refractory Helicobacter bilis leg ulcers. Helicobacter species are known for extracellular colonization and are challenging to culture, necessitating molecular diagnostics for identification. The patient required prolonged treatment with intravenous meropenem followed by oral metronidazole and doxycycline for resolution of the ulcers over two years. The patient also exhibited persistent asymptomatic thrombocytopenia, an atypical finding in CD79A mutation cases. This case underscores the importance of genetic diagnosis and targeted antimicrobial therapy in managing rare infections associated with primary immunodeficiencies like autosomal recessive agammaglobulinemia due to CD79A mutation.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10875-024-01792-9DOI Listing

Publication Analysis

Top Keywords

cd79a mutation
12
refractory helicobacter
8
helicobacter bilis
8
autosomal recessive
8
recessive agammaglobulinemia
8
expanding clinical
4
clinical phenotype
4
cd79a
4
phenotype cd79a
4
mutation refractory
4

Similar Publications

Lymphomas of T-follicular helper origin (T-follicular helper-cell lymphoma [TFHL]) are often accompanied by an expansion of B-immunoblasts, occasionally with Hodgkin/Reed-Sternberg-like (HRS-like) cells, making the differential diagnosis with classic Hodgkin lymphoma (CHL) difficult. We compared the morphologic, immunophenotypic, and molecular features of 15 TFHL and 12 CHL samples and discussed 4 challenging cases of uncertain diagnosis. Compared with CHL, TFHL disclosed more frequent sparing of subcortical sinuses, high-endothelium venule proliferation, dendritic cell meshwork expansion, T-cell atypia, and aberrant T-cell immunophenotype.

View Article and Find Full Text PDF

[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

December 2024

Department of Hematology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

Objective: To investigate the clinical features, gene mutation profile, efficacy and prognostic factors of primary extranodal diffuse large B-cell lymphoma(EN-DLBCL).

Methods: A retrospective analysis was performed for 382 patients with primary EN-DLBCL with complete clinical data who were treated in West China Hospital from January 2013 to January 2023, and their clinical characteristics,gene mutation profile, efficacy and prognostic factors were analyzed.

Results: The median age of the 382 patients with EN-DLBCL was 56(18-89) years old.

View Article and Find Full Text PDF

Contemporary studies of Bruton tyrosine kinase inhibitor (BTKi) resistance focus on mutations in the B-cell receptor (BCR) pathway, but alternative mechanisms of resistance remain undefined. Here, we sought to identify novel predictive markers of acquired resistance to acalabrutinib, a second-generation BTKi, in patients with chronic lymphocytic leukemia (CLL). Clinical samples from 41 patients with relapsed/refractory or treatment-naive CLL receiving acalabrutinib as part of a clinical trial (NCT02029443) were divided into two groups: those who continued to respond to treatment (NP, n = 23) and those who developed progressive disease on acalabrutinib therapy (PD, n = 18).

View Article and Find Full Text PDF

Primary seminal vesicle lymphoma is a remarkably rare condition, predominantly manifesting as diffuse large B-cell lymphoma. Due to its rarity and nonspecific clinical presentations, it is often misdiagnosed or overlooked. Here, we report a case of a 68-year-old male diagnosed with primary seminal vesicle lymphoma, coinciding with prostate cancer.

View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed the clinicopathological features and genetic mutations of pulmonary intravascular large B cell lymphoma in eight patients between April 2018 and May 2023, revealing a median age of 64 and a predominance of respiratory symptoms.
  • - High-resolution chest CT scans showed diffuse ground-glass opacities in the lungs, with pulmonary function tests indicating varying degrees of dysfunction; most patients had elevated serum markers indicating advanced disease.
  • - Genetic testing identified MYD88 and PIM1 as the most frequently mutated genes, while tumor cells exhibited characteristics typical of large B cell lymphoma and were found infiltrating blood vessels throughout the lung tissue.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!